SBC Medical Group Holdings Incorporated
NASDAQ:SBCConsulting Services
+$0.04 today
- Market cap
- $644.85M
- Beta
- 0.59
- P/E (TTM)
- 7.6
- EPS (TTM)
- $0.40
Volume 0.56M
Average 0.12M
Returns on capital
SBC Medical Group Holdings Incorporated management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
20.5%
avg 19.5%
ROIC
12.6%
avg 14.7%
ROA
13.4%
avg 12.2%
Analysis
ROE is currently the strongest return metric at 20.5% versus its period average of 19.5%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Yoshiyuki Aikawa | Chairman & Chief Executive Officer | USD 12M | 55 | 78.84M | 76.66% |
Miki Yamazaki | Chief Strategy Officer | USD 463.7K | 40 | 0 | <0.01% |
Yuya Yoshida | Chief Operating Officer, Chief Financial Officer & Director | USD 416.07K | 46 | 0 | <0.01% |
Ryoji Murata | Principal Accounting Officer | USD 136.99K | 54 | 0 | <0.01% |
Hikaru Fukui | Head of IR & CHRO of SBC Medical Group Co., Ltd. (Japan) | — | — | — | — |
Hiroyuki Miya | Chief Operating Officer of SBC Medical Group Co., Ltd. (Japan) | — | — | — | — |
Kazuki Ichimori | Chief Corporate Development Officer | — | — | — | — |
Shinya Inoue | Chief Marketing Officer | — | — | — | — |
Akiko Wakiyama | Chief Public Relations Officer | — | — | — | — |
Taiki Sakaguchi | CHRO, Chief Planning Officer & Corporate Secretary | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Apr 28, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
3
$20.15M
Net Transaction Value
−$20.15M
Net selling
Most Active
Aikawa Yoshiyuki
3 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Apr 28, 26Apr 28, 2026 | Aikawa Yoshiyuki Direct | Sell | $1.4M$1,405,462.50 |
| Apr 21, 26Apr 21, 2026 | Aikawa Yoshiyuki Direct | Sell | $9.4M$9,369,750.00 |
| Mar 6, 26Mar 6, 2026 | Aikawa Yoshiyuki Indirect | Sell | $9.4M$9,376,548.00 |
Summary
Insiders reported 0 buys worth $0.00 and 3 sells worth $20.15M over the last 12 months. That adds up to net selling of $20.15M. Aikawa Yoshiyuki was the most active insider with 3 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +99.8% | +2.8% (3yr)1 analysts |
| Revenue | N/A | N/A | -0.1% | +10.9% (3yr)2 analysts |
| Net Income | N/A | N/A | +100.6% | +3.0% (3yr)2 analysts |
| EBIT | N/A | N/A | +49.7% | +1.5% (3yr)2 analysts |
Analysis
Recent growth has been strongest in Net Income at +100.6% over three years. Forward estimates point to Revenue at +10.9% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does SBC Medical Group Holdings Incorporated compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about SBC's management, answered from reported figures.
Who manages SBC?
SBC Medical Group Holdings Incorporated (SBC) lists 10 active executives. The top listed executive is Yoshiyuki Aikawa, Chairman & Chief Executive Officer.
Are SBC insiders buying or selling?
Recent insider activity shows net selling of $20.11M.
Continue the stock analysis
Jump to another research area for this company.